NLS Collaboration

Collaboration - June 21, 2021

SAGA Diagnostics expands research collaboration

The company has announced an expanded research collaboration with Professor Charles Swanton, at the University College London (UCL) Cancer Institute. Last year, SAGA and UCL entered into a research collaboration on a limited number of patients. With the newly signed agreement, SAGA will utilize its SAGAsafe assays for detection of a panel of mutations in […]

Collaboration - June 16, 2021

Pilloxa enters new collaboration

Pilloxa has announced that it is to collaborate with the Nordic office of Chiesi Global Rare Diseases on using the company’s platform to support the treatment journey for patients with nephropathic cystinosis across Scandinavia. “We are honored to work with the Nordic office of Chiesi Global Rare Diseases to support patients, an incredible partner within […]

Collaboration - June 2, 2021

SciLifeLab enters new collaboration with EMBL

SciLifeLab and The European Molecular Biology Laboratory (EMBL) will intensify collaboration between the two organizations under the joint Memorandum of Understanding (MoU). The MoU declares a joint ambition to stimulate mutually beneficial scientific and academic exchange and collaboration in various areas of life science research in order to ensure greater connectivity, availability of scientific data, […]

Collaboration - May 27, 2021

OnDosis expands collaboration with Tiefenbacher Group

OnDosis and German B2B pharmaceutical company Tiefenbacher Group initiate four new development projects targeting ADHD, rare diseases and transplantation medicine. Last year, the two companies began cooperating on an ADHD treatment that has already received attention in the USA, states the company in a press release. “Whilst our first ADHD project fast approaches final stages […]

Collaboration - May 27, 2021

Nanoform and Celanese announce plans to collaborate

Nanoform and Celanese Corporation have announced plans to explore the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery. The goal is to assess the utility of combining Nanoform’s nanoparticle platform technologies with Celanese’s VitalDose EVA copolymer delivery technology for drug-eluting implants, states Nanoform in a press release. The aims are to […]

Collaboration - May 25, 2021

LINK Medical and Medaffcon collaborate

LINK Medical and Medaffcon have announced their collaboration to provide customers with integrated, full-service Real World Evidence (RWE) and Market Access support across all Nordic countries. “We are excited to collaborate with LINK Medical and expand our RWE services across the Nordics, facilitating our customers with local knowledge and expertise. Through this collaboration we are […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.